Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

FHL1 is a major host factor for chikungunya virus infection.

Meertens L, Hafirassou ML, Couderc T, Bonnet-Madin L, Kril V, Kümmerer BM, Labeau A, Brugier A, Simon-Loriere E, Burlaud-Gaillard J, Doyen C, Pezzi L, Goupil T, Rafasse S, Vidalain PO, Bertrand-Legout A, Gueneau L, Juntas-Morales R, Ben Yaou R, Bonne G, de Lamballerie X, Benkirane M, Roingeard P, Delaugerre C, Lecuit M, Amara A.

Nature. 2019 Oct;574(7777):259-263. doi: 10.1038/s41586-019-1578-4. Epub 2019 Sep 25.

PMID:
31554973
2.

IFITM proteins inhibit placental syncytiotrophoblast formation and promote fetal demise.

Buchrieser J, Degrelle SA, Couderc T, Nevers Q, Disson O, Manet C, Donahue DA, Porrot F, Hillion KH, Perthame E, Arroyo MV, Souquere S, Ruigrok K, Dupressoir A, Heidmann T, Montagutelli X, Fournier T, Lecuit M, Schwartz O.

Science. 2019 Jul 12;365(6449):176-180. doi: 10.1126/science.aaw7733.

PMID:
31296770
3.

The Unfolded Protein Response: A Key Player in Zika Virus-Associated Congenital Microcephaly.

Alfano C, Gladwyn-Ng I, Couderc T, Lecuit M, Nguyen L.

Front Cell Neurosci. 2019 Mar 26;13:94. doi: 10.3389/fncel.2019.00094. eCollection 2019.

4.

Arboviruses and pregnancy: maternal, fetal, and neonatal effects.

Charlier C, Beaudoin MC, Couderc T, Lortholary O, Lecuit M.

Lancet Child Adolesc Health. 2017 Oct;1(2):134-146. doi: 10.1016/S2352-4642(17)30021-4. Epub 2017 Aug 10. Review.

PMID:
30169203
5.

Zika virus infects human testicular tissue and germ cells.

Matusali G, Houzet L, Satie AP, Mahé D, Aubry F, Couderc T, Frouard J, Bourgeau S, Bensalah K, Lavoué S, Joguet G, Bujan L, Cabié A, Avelar G, Lecuit M, Le Tortorec A, Dejucq-Rainsford N.

J Clin Invest. 2018 Oct 1;128(10):4697-4710. doi: 10.1172/JCI121735. Epub 2018 Jul 31.

6.

A clinical and histopathological study of malformations observed in fetuses infected by the Zika virus.

Beaufrère A, Bessières B, Bonnière M, Driessen M, Alfano C, Couderc T, Thiry M, Thelen N, Lecuit M, Attié-Bitach T, Vekemans M, Ville Y, Nguyen L, Leruez-Ville M, Encha-Razavi F.

Brain Pathol. 2019 Jan;29(1):114-125. doi: 10.1111/bpa.12644. Epub 2018 Oct 5.

PMID:
30020561
7.

Conformational Plasticity in Broadly Neutralizing HIV-1 Antibodies Triggers Polyreactivity.

Prigent J, Jarossay A, Planchais C, Eden C, Dufloo J, Kök A, Lorin V, Vratskikh O, Couderc T, Bruel T, Schwartz O, Seaman MS, Ohlenschläger O, Dimitrov JD, Mouquet H.

Cell Rep. 2018 May 29;23(9):2568-2581. doi: 10.1016/j.celrep.2018.04.101.

8.

Antibody-mediated enhancement aggravates chikungunya virus infection and disease severity.

Lum FM, Couderc T, Chia BS, Ong RY, Her Z, Chow A, Leo YS, Kam YW, Rénia L, Lecuit M, Ng LFP.

Sci Rep. 2018 Jan 30;8(1):1860. doi: 10.1038/s41598-018-20305-4.

9.

Stress-induced unfolded protein response contributes to Zika virus-associated microcephaly.

Gladwyn-Ng I, Cordón-Barris L, Alfano C, Creppe C, Couderc T, Morelli G, Thelen N, America M, Bessières B, Encha-Razavi F, Bonnière M, Suzuki IK, Flamand M, Vanderhaeghen P, Thiry M, Lecuit M, Nguyen L.

Nat Neurosci. 2018 Jan;21(1):63-71. doi: 10.1038/s41593-017-0038-4. Epub 2017 Dec 11.

PMID:
29230053
10.

Chikungunya virus-associated encephalitis: A cohort study on La Réunion Island, 2005-2009.

Oliveira JR, Gérardin P, Couderc T, Randrianaivo H, Fritel X, Lecuit M.

Neurology. 2016 May 24;86(21):2025-6. doi: 10.1212/WNL.0000000000002732. No abstract available.

PMID:
27217467
11.

A human genome-wide loss-of-function screen identifies effective chikungunya antiviral drugs.

Karlas A, Berre S, Couderc T, Varjak M, Braun P, Meyer M, Gangneux N, Karo-Astover L, Weege F, Raftery M, Schönrich G, Klemm U, Wurzlbauer A, Bracher F, Merits A, Meyer TF, Lecuit M.

Nat Commun. 2016 May 12;7:11320. doi: 10.1038/ncomms11320.

12.

Chikungunya virus-associated encephalitis: A cohort study on La Réunion Island, 2005-2009.

Gérardin P, Couderc T, Bintner M, Tournebize P, Renouil M, Lémant J, Boisson V, Borgherini G, Staikowsky F, Schramm F, Lecuit M, Michault A; Encephalchik Study Group.

Neurology. 2016 Jan 5;86(1):94-102. doi: 10.1212/WNL.0000000000002234. Epub 2015 Nov 25.

13.

Chikungunya virus pathogenesis: From bedside to bench.

Couderc T, Lecuit M.

Antiviral Res. 2015 Sep;121:120-31. doi: 10.1016/j.antiviral.2015.07.002. Epub 2015 Jul 6. Review.

14.

Therapeutics and vaccines against chikungunya virus.

Ahola T, Couderc T, Ng LF, Hallengärd D, Powers A, Lecuit M, Esteban M, Merits A, Roques P, Liljeström P.

Vector Borne Zoonotic Dis. 2015 Apr;15(4):250-7. doi: 10.1089/vbz.2014.1681. Review. Erratum in: Vector Borne Zoonotic Dis. 2015 Nov;15(11):712. Courderc, Therese [Corrected to Couderc, Therese].

PMID:
25897811
15.

Chikungunya virus pathogenesis and immunity.

Gasque P, Couderc T, Lecuit M, Roques P, Ng LF.

Vector Borne Zoonotic Dis. 2015 Apr;15(4):241-9. doi: 10.1089/vbz.2014.1710. Review.

PMID:
25897810
16.

Live rubella virus vaccine long-term persistence as an antigenic trigger of cutaneous granulomas in patients with primary immunodeficiency.

Bodemer C, Sauvage V, Mahlaoui N, Cheval J, Couderc T, Leclerc-Mercier S, Debré M, Pellier I, Gagnieur L, Fraitag S, Fischer A, Blanche S, Lecuit M, Eloit M.

Clin Microbiol Infect. 2014 Oct;20(10):O656-63. doi: 10.1111/1469-0691.12573. Epub 2014 Mar 5.

17.

Virus replicon particle based Chikungunya virus neutralization assay using Gaussia luciferase as readout.

Gläsker S, Lulla A, Lulla V, Couderc T, Drexler JF, Liljeström P, Lecuit M, Drosten C, Merits A, Kümmerer BM.

Virol J. 2013 Jul 15;10:235. doi: 10.1186/1743-422X-10-235.

18.

Species-specific impact of the autophagy machinery on Chikungunya virus infection.

Judith D, Mostowy S, Bourai M, Gangneux N, Lelek M, Lucas-Hourani M, Cayet N, Jacob Y, Prévost MC, Pierre P, Tangy F, Zimmer C, Vidalain PO, Couderc T, Lecuit M.

EMBO Rep. 2013 Jun;14(6):534-44. doi: 10.1038/embor.2013.51. Epub 2013 Apr 26.

19.

Chikungunya virus-associated long-term arthralgia: a 36-month prospective longitudinal study.

Schilte C, Staikowsky F, Couderc T, Madec Y, Carpentier F, Kassab S, Albert ML, Lecuit M, Michault A.

PLoS Negl Trop Dis. 2013;7(3):e2137. doi: 10.1371/journal.pntd.0002137. Epub 2013 Mar 21. Erratum in: PLoS Negl Trop Dis. 2013 Mar;7(3). doi:10.1371/annotation/850ee20f-2641-46ac-b0c6-ef4ae79b6de6. Staikovsky, Frédérik [corrected to Staikowsky, Frederik].

20.

Chikungunya virus infection of corneal grafts.

Couderc T, Gangneux N, Chrétien F, Caro V, Le Luong T, Ducloux B, Tolou H, Lecuit M, Grandadam M.

J Infect Dis. 2012 Sep 15;206(6):851-9. doi: 10.1093/infdis/jis296. Epub 2012 Jun 15.

PMID:
22706183
21.

Induction of GADD34 is necessary for dsRNA-dependent interferon-β production and participates in the control of Chikungunya virus infection.

Clavarino G, Cláudio N, Couderc T, Dalet A, Judith D, Camosseto V, Schmidt EK, Wenger T, Lecuit M, Gatti E, Pierre P.

PLoS Pathog. 2012;8(5):e1002708. doi: 10.1371/journal.ppat.1002708. Epub 2012 May 17.

22.

Protein phosphatase 1 subunit Ppp1r15a/GADD34 regulates cytokine production in polyinosinic:polycytidylic acid-stimulated dendritic cells.

Clavarino G, Cláudio N, Dalet A, Terawaki S, Couderc T, Chasson L, Ceppi M, Schmidt EK, Wenger T, Lecuit M, Gatti E, Pierre P.

Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):3006-11. doi: 10.1073/pnas.1104491109. Epub 2012 Feb 6.

23.

Mapping of Chikungunya virus interactions with host proteins identified nsP2 as a highly connected viral component.

Bouraï M, Lucas-Hourani M, Gad HH, Drosten C, Jacob Y, Tafforeau L, Cassonnet P, Jones LM, Judith D, Couderc T, Lecuit M, André P, Kümmerer BM, Lotteau V, Desprès P, Tangy F, Vidalain PO.

J Virol. 2012 Mar;86(6):3121-34. doi: 10.1128/JVI.06390-11. Epub 2012 Jan 18.

24.

Type I IFN controls chikungunya virus via its action on nonhematopoietic cells.

Schilte C, Couderc T, Chretien F, Sourisseau M, Gangneux N, Guivel-Benhassine F, Kraxner A, Tschopp J, Higgs S, Michault A, Arenzana-Seisdedos F, Colonna M, Peduto L, Schwartz O, Lecuit M, Albert ML.

J Exp Med. 2010 Feb 15;207(2):429-42. doi: 10.1084/jem.20090851. Epub 2010 Feb 1.

25.

Focus on Chikungunya pathophysiology in human and animal models.

Couderc T, Lecuit M.

Microbes Infect. 2009 Dec;11(14-15):1197-205. doi: 10.1016/j.micinf.2009.09.002. Epub 2009 Sep 6. Review.

PMID:
19737626
26.

Prophylaxis and therapy for Chikungunya virus infection.

Couderc T, Khandoudi N, Grandadam M, Visse C, Gangneux N, Bagot S, Prost JF, Lecuit M.

J Infect Dis. 2009 Aug 15;200(4):516-23. doi: 10.1086/600381.

PMID:
19572805
27.

Dynamics of immune cell recruitment during West Nile encephalitis and identification of a new CD19+B220-BST-2+ leukocyte population.

Bréhin AC, Mouriès J, Frenkiel MP, Dadaglio G, Desprès P, Lafon M, Couderc T.

J Immunol. 2008 May 15;180(10):6760-7.

28.

Multidisciplinary prospective study of mother-to-child chikungunya virus infections on the island of La Réunion.

Gérardin P, Barau G, Michault A, Bintner M, Randrianaivo H, Choker G, Lenglet Y, Touret Y, Bouveret A, Grivard P, Le Roux K, Blanc S, Schuffenecker I, Couderc T, Arenzana-Seisdedos F, Lecuit M, Robillard PY.

PLoS Med. 2008 Mar 18;5(3):e60. doi: 10.1371/journal.pmed.0050060.

29.

A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease.

Couderc T, Chrétien F, Schilte C, Disson O, Brigitte M, Guivel-Benhassine F, Touret Y, Barau G, Cayet N, Schuffenecker I, Desprès P, Arenzana-Seisdedos F, Michault A, Albert ML, Lecuit M.

PLoS Pathog. 2008 Feb 8;4(2):e29. doi: 10.1371/journal.ppat.0040029.

30.

Poliovirus, pathogenesis of poliomyelitis, and apoptosis.

Blondel B, Colbère-Garapin F, Couderc T, Wirotius A, Guivel-Benhassine F.

Curr Top Microbiol Immunol. 2005;289:25-56. Review.

PMID:
15791950
31.

Poliovirus and apoptosis.

Blondel B, Couderc T, Simonin Y, Gosselin AS, Guivel-Benhassine F.

Prog Mol Subcell Biol. 2004;36:151-69. Review. No abstract available.

PMID:
15171611
32.

Poliovirus-induced apoptosis is reduced in cells expressing a mutant CD155 selected during persistent poliovirus infection in neuroblastoma cells.

Gosselin AS, Simonin Y, Guivel-Benhassine F, Rincheval V, Vayssière JL, Mignotte B, Colbère-Garapin F, Couderc T, Blondel B.

J Virol. 2003 Jan;77(1):790-8.

33.

An ex vivo murine model to study poliovirus-induced apoptosis in nerve cells.

Couderc T, Guivel-Benhassine F, Calaora V, Gosselin AS, Blondel B.

J Gen Virol. 2002 Aug;83(Pt 8):1925-30.

PMID:
12124456
34.

Restriction of poliovirus RNA replication in persistently infected nerve cells.

Girard S, Gosselin AS, Pelletier I, Colbère-Garapin F, Couderc T, Blondel B.

J Gen Virol. 2002 May;83(Pt 5):1087-93.

PMID:
11961263
35.

Poliovirus persistence in human cells in vitro.

Colbère-Garapin F, Jacques S, Drillet AS, Pavio N, Couderc T, Blondel B, Pelletier I.

Dev Biol (Basel). 2001;105:99-104.

PMID:
11763344
36.

Inhibition of poliovirus RNA synthesis as a molecular mechanism contributing to viral persistence in the mouse central nervous system.

Couderc T, Girard S, Pelletier I, Gosselin AS, Destombes J, Thiesson D, Colbère-Garapin F, Blondel B.

Dev Biol (Basel). 2001;105:225-30.

PMID:
11763332
37.

Expression of mutated poliovirus receptors in human neuroblastoma cells persistently infected with poliovirus.

Pavio N, Couderc T, Girard S, Sgro JY, Blondel B, Colbère-Garapin F.

Virology. 2000 Sep 1;274(2):331-42.

38.

Poliovirus induces apoptosis in the mouse central nervous system.

Girard S, Couderc T, Destombes J, Thiesson D, Delpeyroux F, Blondel B.

J Virol. 1999 Jul;73(7):6066-72.

39.

Molecular aspects of poliovirus biology with a special focus on the interactions with nerve cells.

Blondel B, Duncan G, Couderc T, Delpeyroux F, Pavio N, Colbère-Garapin F.

J Neurovirol. 1998 Feb;4(1):1-26. Review.

PMID:
9531008
40.

Persistent poliovirus infection in mouse motoneurons.

Destombes J, Couderc T, Thiesson D, Girard S, Wilt SG, Blondel B.

J Virol. 1997 Feb;71(2):1621-8.

41.

Mouse adaptation determinants of poliovirus type 1 enhance viral uncoating.

Couderc T, Delpeyroux F, Le Blay H, Blondel B.

J Virol. 1996 Jan;70(1):305-12.

43.

Persistent poliovirus infection: development of new models with cell lines.

Calvez V, Pelletier I, Guedo N, Borzakian S, Couderc T, Blondel B, Colbere-Garapin F.

Ann N Y Acad Sci. 1995 May 25;753:370-3. No abstract available.

PMID:
7611647
44.

Substitutions in the capsids of poliovirus mutants selected in human neuroblastoma cells confer on the Mahoney type 1 strain a phenotype neurovirulent in mice.

Couderc T, Guédo N, Calvez V, Pelletier I, Hogle J, Colbère-Garapin F, Blondel B.

J Virol. 1994 Dec;68(12):8386-91.

46.

[Palliative treatment by endoprosthesis of icterus caused by distal biliary tumoral obstruction].

Buffet C, Couderc T, Fritsch J, Choury A, Lefebvre JF, Marteau V, Ink O, Bonnel D, Liguory C, Etienne JP.

Gastroenterol Clin Biol. 1993;17(10):629-35. French.

PMID:
7507069
47.

Persistent poliovirus infection: establishment and maintenance involve distinct mechanisms.

Borzakian S, Couderc T, Barbier Y, Attal G, Pelletier I, Colbère-Garapin F.

Virology. 1992 Feb;186(2):398-408.

PMID:
1310176
48.
49.

Characterization of persistent poliovirus mutants selected in human neuroblastoma cells.

Pelletier I, Couderc T, Borzakian S, Wyckoff E, Crainic R, Ehrenfeld E, Colbere-Garapin F.

Virology. 1991 Feb;180(2):729-37.

PMID:
1846495
50.

Use of type 1/type 2 chimeric polioviruses to study determinants of poliovirus type 1 neurovirulence in a mouse model.

Martin A, Benichou D, Couderc T, Hogle JM, Wychowski C, Van der Werf S, Girard M.

Virology. 1991 Feb;180(2):648-58.

PMID:
1846492

Supplemental Content

Loading ...
Support Center